Tibet Weixinkang Pharmaceutical announced that its wholly-owned subsidiary Baiyi Pharmaceutical's pediatric multi-vitamins injection will be renewed into the "National Medical Insurance Catalog" during the agreement period. This pharmaceutical is an exclusive variety, suitable for preventing vitamin deficiency in patients under 11 years old receiving parenteral nutrition. Sales revenue reached 45.507 million yuan in 2023, accounting for 3.44% of the company's current revenue; in the first three quarters of 2024, sales revenue reached 52.4323 million yuan, accounting for 5.27% of the company's current revenue. The inclusion in the medical insurance catalog this time will benefit the market promotion and sales of the product, further consolidating the company's market position in the field of intravenous vitamin supplements.
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD1800!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Join Futubull Membership ProgramUnlock 11 Premier Benefits
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Learn PremiumAnalyst 1V1 online teaching
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
- Latest
- Detail
卫信康:小儿多种维生素注射液续约纳入国家医保目录
Tibet Weixinkang Pharmaceutical: Pediatric multi-vitamins injection renewed into the national medical insurance catalog.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
02:04
LME copper futures rose by $110, closing at $9,232 per ton. LME aluminum futures fell by $0.16, closing at $2,588 per ton. LME zinc futures rose by $54, closing at $3,126 per ton. LME lead futures fell by $4, closing at $2,068 per ton. LME nickel futures fell by $51, closing at $15,996 per ton. LME tin futures rose by $767, closing at $29,918 per ton. LME cobalt futures remained unchanged, closing at $24,300 per ton.
02:03
Dell Technologies: COREWEAVE integrates its cloud computing service platform with the dell ai factory and nvidia.
DELL-0.43%
02:02
The CEO of T-MOBILE stated that the company only has 60% of its mid-band spectrum allocated for 5G.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.